newsfilter
← Latest News
Business Wire·

NeoGenomics to Report Third Quarter 2026 Financial Results on October 28, 2026

NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced that it will report its third quarter 2026 financial results after the close of the